A. Wong

发表

Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?

A. Chan, A. Wong, D. Jenken, 2010, International journal of radiation oncology, biology, physics.

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.

A. Chan, A. Wong, D. Jenken, 2003, International journal of radiation oncology, biology, physics.

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

W. Scheithauer, C. Twelves, J. Cassidy, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid.

C. Erlichman, T. Gadalla, A. Wong, 1992, European journal of cancer.

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

J. S. Kim, M. Espié, Sung-Bae Kim, 2021, Breast Cancer Research and Treatment.

1LB 5-year overall survival update from the X-ACT trial of capecitabine vs. 5-FU/LV as adjuvant treatment for stage-III colon cancer

W. Scheithauer, C. Twelves, J. Cassidy, 2007 .

Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial.

W. Scheithauer, C. Twelves, J. Cassidy, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.

R. Schilsky, R. Pazdur, M. Thirlwell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study)

J. Zaluski, J. Douillard, C. Twelves, 2003 .

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

E Harrison, H. Burger, G. Batist, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

C. Erlichman, A. Wong, S. Fine, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Capecitabine as adjuvant treatment for stage III colon cancer.

Markus Abt, Joseph McKendrick, Marek Pawlicki, 2005, The New England journal of medicine.

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.

W. Scheithauer, J. Zaluski, H. Burris, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study.

A. Chan, A. Wong, D. Jenken, 2000, International journal of radiation oncology, biology, physics.

Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.

W. Miller, D. Haller, G. Bodoky, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

"Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.

W. Buie, A. Chan, A. Wong, 1997, International journal of radiation oncology, biology, physics.

Preoperative concurrent 5-fluorouracil infusion, mitomycin C and pelvic radiation therapy in tethered and fixed rectal carcinoma.

A. Wong, A. Chan, A. Wong, 1993, International journal of radiation oncology, biology, physics.

Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma.

A. Wong, A. Chan, A. Wong, 1989, International journal of radiation oncology, biology, physics.

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

W. Scheithauer, C. Twelves, J. Cassidy, 2012 .

Updated efficacy findings from the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes’ C colon cancer

J. Douillard, C. Twelves, J. Cassidy, 2005 .